Show Less
Restricted access

Patents, Pills, and the Press

The Rise and Fall of the Global HIV/AIDS Medicines Crisis in the News

Series:

Thomas Owen

HIV/AIDS is a global health crisis of unprecedented proportions. Afflicting millions worldwide, its social, political, economic, and ethical dimensions have rendered explicit the vast inequalities of our «negatively globalized planet». Since the late 1990s, a major feature of the crisis has been the dispute over intellectual property protection and medicines access.
In this book, Thomas Owen examines the mediatization of this dispute. Weaving together contemporary media theory and interdisciplinary research with computer-assisted news analysis and interviews with journalists and civil society campaigners, the book illuminates the intersecting constitutive relationships between global crises, global governance, and global media. In a context of changing media technologies, logics, and practices, this book observes where the mediatized conflict surrounding global medicines access has at times consolidated elite political economic power, and at other times provided civil society campaigners their greatest opportunities for global social change.
With an interdisciplinary approach, this book is suitable for courses on global media communication and global journalism, as well as advanced undergraduate and postgraduate courses in public health communication, political communication, social movement studies, and international relations.
Show Summary Details
Restricted access

References

Extract



‘t Hoen, E. (1999). Access to essential drugs and globalization. Development, 42(4), 87–91.

‘t Hoen, E. (2000). Doctors in Seattle: The battle for access to essential drugs. Development, 43 (2), 101–105.

‘t Hoen, E. (2002). TRIPS, pharmaceutical patents, and access to essential medicines: A long way from Seattle to Doha. Chicago Journal of International Law, 3 (1), 27–46.

‘t Hoen, E. (2009). The global politics of pharmaceutical monopoly power: Drug patents, access, innovation and the application of the WTO Doha Declaration on TRIPS and public health . Diemen, the Netherlands: AMB.

‘t Hoen, E., Berger, J., Calmy, A., & Moon, S. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society, 14 (15), 1–12.

Abbas, M. Z., & Riaz, S. (2013). Evolution of the Concept of Compulsory Licensing: A Critical Analysis of Key Developments Before and After TRIPS. Academic Research International, 4 (2), 482–499.

Abbott, F. M. (2004). The Doha Declaration on the TRIPS agreement and public health and the contradictory trend in bilateral and regional free trade agreements . Retrieved from www.quno.org/geneva/pdf/economic/Occassional/TRIPS–Public-Health-FTAs.pdf

Abelson, R. (28 April 2003). Glaxo Will Further Cut Prices of AIDS Drugs to Poor Nations. The New York Times, p. 2.

You are not authenticated to view the full text of this chapter or article.

This site requires a subscription or purchase to access the full text of books or journals.

Do you have any questions? Contact us.

Or login to access all content.